back to Meetings page
Participants
Agenda
Background Materials
  • IMMPACT-XVIII Slide Presentations

  • 1. A regulatory perspective on threats to the integrity of analgesic clinical trial efficacy data
  • Sharon Hertz, MD
  • 2. Clinical trial quality: what is it, and what approaches can optimize it?
  • Nathaniel Katz, MD
  • 3. Pain reporting: patient training, compliance, and monitoring
  • Mark Jensen, PhD
  • 4. Fabrication and concealment by clinical trial participants
  • Eric Devine, PhD
  • 5. Combating participant misbehavior in analgesic clinical trials
  • Robert Dworkin, PhD
  • 6. Evaluating and enhancing adherence to medications
  • Bernard Vrijens, PhD
  • 7. A regulatory perspective on electronic data capture
  • Sarrit Kovacs, PhD
  • 8. Site selection, training, and surveillance
  • Richard Malamut, MD
  • 9. Central statistical monitoring
  • Amy Kirkwood, MSc
  • 10. Data quality issues in the design and analysis of clinical trials: an FDA perspective
  • Paul Schuette, PhD
  • 11. An academic perspective on clinical trial quality
  • John Markman, MD
  •  
  • 12. Industry and CRO perspectives on clinical trial quality
  • David Hewitt, MD